Fri, May 24, 2013, 9:34 PM EDT - U.S. Markets closed
for who knows what.
TTNP has a priority review PDUFA on April 30 for the huge opiate addiction market.
Millions are addicted to pain meds and illicit drugs.
TTNP has a 6 month slow release abuse proof implant for this epidemic.
Its ProNeura technology is also being advanced for Parkinson's and chronic pain.
A $50 million milestone will be received 4/30 upon approval plus tiered double digit royalties.